Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I
Clinical trial NCT00171925 · TERMINATED
Trial details
- NCT number
- NCT00171925
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-08-01
- Primary completion
- 2008-11-01
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.